Randomized controlled crossover trials of the pharmacokinetics of PRC-063, a novel multilayer extended-release formulation of methylphenidate, in healthy adults

Authors

Martin A. Katzman, Lakehead University
Greg Mattingly, Washington University School of Medicine in St. Louis
Larry J. Klassen, Eden Mental Health Centre
Marc J. Cataldo, Purdue Pharma L. P.
Graeme A. E. Donnelly, Purdue Pharma Canada

Journal

Journal of Clinical Psychopharmacology

Publication Date

2020

Volume

40

Issue

6

First Page

579

Last Page

587

Document Type

Open Access Publication

DOI

10.1097/JCP.0000000000001277

Rights and Permissions

Katzman MA, Mattingly G, Klassen LJ, Cataldo MJ, Donnelly GAE. Randomized Controlled Crossover Trials of the Pharmacokinetics of PRC-063, a Novel Multilayer Extended-Release Formulation of Methylphenidate, in Healthy Adults. J Clin Psychopharmacol. 2020 Nov/Dec;40(6):579-587. doi: 10.1097/JCP.0000000000001277 Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

Recommended Citation

Katzman, Martin A.; Mattingly, Greg; Klassen, Larry J.; Cataldo, Marc J.; and Donnelly, Graeme A. E., "Randomized controlled crossover trials of the pharmacokinetics of PRC-063, a novel multilayer extended-release formulation of methylphenidate, in healthy adults." Journal of Clinical Psychopharmacology. 40, 6. 579 - 587. (2020).
https://digitalcommons.wustl.edu/open_access_pubs/10767